Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

NCT: NCT05489588 · RECRUITING

NCT IDNCT05489588
StatusRECRUITING
Start Date2023-03-02
Completion2031-03

Brief Summary

This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic iliofemoral venous obstruction.

Frequently Asked Questions

What is The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study?

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study is a clinical trial registered under NCT05489588. Current status: RECRUITING.

What is the status of NCT05489588?

The current status of NCT05489588 (The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study) is: RECRUITING.

When did The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study start?

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study started on 2023-03-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑